Related Experiment Video
Updated: Nov 14, 2025

Assessment of Glutamine as a Fuel Source for Alveolar Macrophages Exposed to Chronic Ethanol Using an Extracellular Flux Bioanalyzer
Published on: November 15, 2024
Management of COVID-19 infection in organic acidemias
Shagun Kaur1, Stephanie L Campbell1, David W Stockton1,2
1Division of Genetic, Genomic, and Metabolic Disorders, Children's Hospital of Michigan, Detroit, Michigan, USA.
Insights
COVID-19 infection can cause metabolic decompensation in children with inborn errors of metabolism (IEM). SARS-CoV-2 did not worsen metabolic decline beyond typical expectations for these patients.
Area of Science:
- Infectious Diseases
- Metabolic Disorders
- Pediatric Health
Background:
- The COVID-19 pandemic has had a global impact on health, with pediatric cases generally showing milder symptoms.
- Limited research exists on Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2) infections in children with inborn errors of metabolism (IEM).
Observation:
- This report details two pediatric patients with underlying metabolic disorders: propionic acidemia and glutaric aciduria type 1.
- The patients' clinical presentations, infectious disease management, and metabolic care during SARS-CoV-2 infection are discussed.
Findings:
- Individuals with IEM are susceptible to metabolic decompensation when infected with SARS-CoV-2.
- The severity of metabolic deterioration from SARS-CoV-2 infection in these patients was consistent with their typical metabolic challenges.
Implications:
- Children with inborn errors of metabolism require careful monitoring for metabolic decompensation during COVID-19 infections.
- Understanding the interaction between SARS-CoV-2 and IEM is crucial for effective clinical management and patient outcomes.
Abstract:
The COVID-19 pandemic has affected the health and healthcare of individuals of all ages worldwide. There have been multiple reports and reviews documenting a milder effect and decreased morbidity and mortality in the pediatric population, but there have only been a small number of reports discussing the SARS-CoV-2 infection in the setting of an inborn error of metabolism (IEM). Here, we report two patients with underlying metabolic disorders, propionic acidemia and glutaric aciduria type 1, and discuss their clinical presentation, as well as their infectious and metabolic management. Our report demonstrates that individuals with an underlying IEM are at risk of metabolic decompensation in the setting of a COVID-19 infection. The SARS-CoV-2 virus does not appear to cause a more severe metabolic deterioration than is typical.
More Related Videos
Related Concept Videos
Diagnosing Acidosis and Alkalosis
First, the pH level is assessed to determine whether the blood pH is normal (7.35–7.45), low (acidosis), or high (alkalosis).
Next, the PCO2 and...
Disorders of Acid-Base Balance
Respiratory Acidosis and Alkalosis
Respiratory acidosis occurs due to an increase in the partial pressure of carbon dioxide PCO2 in the blood. It often arises from shallow breathing or impaired gas exchange caused by...
Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Acid-Base Balance
When the pH of arterial blood rises above 7.45, it results in a condition called alkalosis. Conversely, a drop below 7.35 leads to...
Overview of Carbohydrate Metabolism
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Cystic Fibrosis: Management
Sinus disease and chronic...

